On Monday, the US Food and Drug Administration expanded its eligibility guidelines for the Pfizer COVID-19 vaccine booster, authorizing children 12 years and older. The FDA also reduced the waiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results